Anselamimab (CAEL-101) is a humanized IgG1-?? monoclonal antibody designed to specifically target serum amyloid A1 (SAA1) amyloid fibrils. This antibody binds with high affinity to the SAA1 amyloid fibrils, a key pathological component in amyloidosis disorders, thereby offering potential for therapeutic intervention and disease-modifying effects in amyloid-related diseases. Anselamimab is utilized primarily in research focused on the pathogenesis and treatment of amyloidosis, making it a valuable tool for both basic research and clinical development studies.
Anselamimab (CAEL-101) is a humanized IgG1-?? monoclonal antibody designed to specifically target serum amyloid A1 (SAA1) amyloid fibrils. This antibody binds with high affinity to the SAA1 amyloid fibrils, a key pathological component in amyloidosis disorders, thereby offering potential for therapeutic intervention and disease-modifying effects in amyloid-related diseases. Anselamimab is utilized primarily in research focused on the pathogenesis and treatment of amyloidosis, making it a valuable tool for both basic research and clinical development studies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
